Skip to main content

Psychedelic Treatments

Soon-to-be published research shows that MDMA brought relief to individuals suffering from post-traumatic stress disorder (PTSD), according to a report published Monday by the New York Times.
Andrew Penn, RN, MS, NP, CNS, APRN-BC, founding member of the Organization of Psychedelic and Entheogenic Nurses (OPENurses) and a Sana Symposium steering committee member, discusses psychedelics that mental health professionals should be familiar…
A Phase II clinical trial conducted in London found that in a select group of patients, doses of psilocybin produced comparable antidepressant effects as escitalopram, a commonly prescribed medication for the treatment of depression.
Ketamine has been demonstrated to be effective in treating mental health disorders, chronic pain and addiction by causing several developments in key areas of the brain associated with these conditions.
Psychedelic Medicine Association president Lynn Marie Morski, MD, Esq., a Sana Symposium steering committee member, discusses the mission of the Psychedelic Medicine Association, bringing psychedelics education to front-line providers who are…
Back to Top